ASIT Biotech S.A. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
7.00
5.00
4.00
-
-
253
Cost of Goods Sold (COGS) incl. D&A
19.00
-
83.00
151.00
206.00
253
Gross Income
12.00
-
79.00
151.00
206.00
253
SG&A Expense
2,292.00
4,306.00
7,558.00
13,794.00
12,373.00
13,071
EBIT
2,304.00
4,321.00
7,637.00
13,282.00
12,579.00
13,324
Non Operating Income/Expense
6.00
-
5.00
1,002.00
588.00
81.30
Interest Expense
32.00
114.00
104.00
96.00
-
481
Pretax Income
2,319.00
4,429.00
7,715.00
12,338.00
11,985.00
14,766.70
Income Tax
-
-
-
1.00
1.00
445.70
Consolidated Net Income
2,319.00
4,429.00
7,715.00
12,339.00
11,986.00
14,321
Net Income
2,319.00
4,429.00
7,715.00
12,339.00
11,986.00
14,321
Net Income After Extraordinaries
2,319.00
4,429.00
7,715.00
12,339.00
11,986.00
14,321
Net Income Available to Common
2,319.00
4,429.00
7,715.00
12,339.00
11,986.00
14,321
EPS (Basic)
0.18
0.35
0.60
1.10
0.94
0.86
Basic Shares Outstanding
12,756.80
12,756.80
12,756.80
11,219.20
12,806.10
16,717.20
EPS (Diluted)
0.18
0.35
0.60
1.10
0.94
0.86
Diluted Shares Outstanding
12,756.80
12,756.80
12,756.80
11,219.20
12,806.10
16,717.20
EBITDA
2,282.00
4,301.00
7,557.00
13,131.00
12,373.00
13,071
Other Operating Expense
-
-
-
663.00
-
-
Non-Operating Interest Income
11.00
6.00
31.00
38.00
6.00
-
About ASIT Biotech
View Profile
